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 11 
The purpose of the study was to report the postoperative outcome, complications and long-12 
term follow-up of the use of a static hydraulic urethral sphincter (SHUS) for the management 13 
of urethral sphincter mechanism incompetence (USMI) in female dogs. Medical records were 14 
reviewed to extract information on long-term (>365days) outcome data. Telephone owner 15 
questionnaire was performed to assess post-operative urinary continence scores (scale 1 to 16 
10, where 10 is complete continence) and the presence and frequency of complications. 17 
Twenty female dogs were included. Mean (±SD) time to follow-up was 1205.1 (±627.4) 18 
days. Median continence score/10 (range) was 3.5 (2-6) preoperatively, and 9.0 (7-10) at the 19 
last follow up. Median continence score was significantly higher at all-time points post-20 
operatively compared to before surgery (P<0.001). Complete continence was achieved in 21 
90% of bitches. Minor complications occurred in 13 bitches and included dysuria (8), bacte-22 
rial cystitis (8), longer urination time (10), incisional seroma (5), urinary retention (3), hema-23 
turia (2) and pain when urinating (2). Major complications occurred in one dog (SHUS re-24 
moved 28 months after placement). Continence scores were sustainably improved in the 25 
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long-term. Complications were mostly minor. Urinary tract infection (UTI) were the most 26 
common but resolved with conventional antibiotic treatment.  27 
 28 
 29 
Introduction 30 
 31 
 Urinary incontinence in dogs is commonly seen in veterinary practice. 1 USMI is the 32 
most common cause of acquired urinary incontinence in female dogs,1 and it is also seen, less 33 
commonly, in males. 2 USMI is a multifactorial condition. Contributory factors include ure-34 
thral tone, urethral length, bladder neck position, hormonal status, neutering status, obesity, 35 
body size and breed.3 Medical management with α-adrenergic agonists, such as phenylpro-36 
panolamine (PPA) or ephedrine, increases sympathetic bladder neck tone and has been shown 37 
to increase maximal urethral closure pressure in cases of urethral sphincter mechanism in-38 
competence. 4 It has been shown to improve urinary incontinence in acquired USMI in up to 39 
85% of dogs. However, between 15 and 27% of female dogs with USMI cases remain refrac-40 
tory to medical management with PPA. 4 5 The same percentage of refractory cases is also 41 
found following treatment with estriol. 6  42 
Surgical management of USMI is recommended when medical management fails or if long-43 
term medical management is not an option. Several different procedures are described for 44 
controlling USMI in bitches including colposuspension, 7 8 9 urethropexy 10 11 or a combina-45 
tion of both, 12 urethral submucosal injections with either collagen, 13 14 15 polytetrafluoroeth-46 
ylene (PTFE) 16 or extracellular matrix bioscaffold, 17 transobturator vaginal tape inside out , 47 
18 19 Dacron coated Silastic sheet urethral sphincter, 20 and most recently, SHUS. 21 22 23,24 48 
Complications reported with these techniques include persistent incontinence (immediate or 49 
delayed), dysuria, urinary obstruction, haematuria and recurrent UTI. 8 11 13 13 15 14 23 21 50 
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 The Static Hydraulic Urethral Sphincter (also known as artificial urethral sphincter) is 51 
a silicone device surgically placed around the urethra. It can be incrementally inflated post-52 
operatively, via a subcutaneous port, to progressively compress the proximal urethra and 53 
achieve continence. Should dysuria result, the SHUS can also be partially or fully deflated. 22  54 
SHUS has been investigated in bitches that have ongoing or recurrent incontinence after sur-55 
gery. A preliminary in vivo experimental study, 25  followed by a clinical pilot study in four 56 
spayed bitches, 22  showed good results up to two years post-operatively, with all dogs 57 
achieving full continence at last follow-up at 26 to 30 months. A larger study (27 dogs, in-58 
cluding three male dogs) was published by the same institution and improved incontinence 59 
scores were seen in all dogs, with a median follow up of 12.5 (6-19) months. 23 This series 60 
also reported minimal complications. The authors of the present study have also previously 61 
reported high success rates and low complication rates for this technique at their institution 62 
but only with a short-term follow-up;21 several reports have defined long-term follow-up as 63 
follow- up of 12 months and over. 26 7  To our knowledge, no studies to date have described 64 
long-term follow-up (> 12 months) of female dogs treated for USMI with SHUS implanta-65 
tion. 66 
The primary aim of this study was therefore to report the long-term ( >12 months)  outcome 67 
of SHUS for the control of USMI in female dogs. A second aim was to document any long-68 
term complications and therefore assess the ongoing safety of the SHUS in dogs with 69 
naturally occurring disease. 70 
 71 
 72 
 73 
 74 
 75 
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 84 
Material and Methods 85 
Inclusion criteria  86 
The study was approved by our institutional Ethical Review Committee. Clinical records and 87 
histories were reviewed for female dogs presenting to the authors institution between January 88 
2009 and December 2015 for evaluation of urinary incontinence. History, physical examina-89 
tion, routine biochemical and haematological analysis, abdominal ultrasound, urinalysis, 90 
urine culture, intravenous contrast urography (IVU) and contrast retrograde vaginourethro-91 
cystogram ± cystoscopic examination were performed in all dogs to rule out other causes of 92 
urinary incontinence. Dogs that were presented with concurrent UTI were treated with antibi-93 
otics selected according to anti-microbial susceptibility testing. USMI was diagnosed if the 94 
incontinence persisted after negative urine culture and imaging of the urogenital tract dis-95 
closed no significant anatomical abnormalities other than an intrapelvic bladder neck location 96 
consistent with USMI. Inclusion criteria included all females in which a SHUS was placed 97 
for the treatment of USMI where adequate records were available. Animals were excluded if 98 
their follow-up was less than 12 months. Long-term follow-up was assessed by a question-99 
naire to owners and or referring veterinarian.  100 
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 101 
Surgical Procedure 102 
 All dogs were investigated and treated at the author’s institution and surgery was per-103 
formed by a board-certified surgeon or a surgical resident under the direct supervision of a 104 
board-certified surgeon. Surgery was performed as previously described. 21 22  105 
 106 
Postoperative care 107 
 Dogs were administered 0·2 to 0·3 mg/kg methadone intravenously (IV) or intramus-108 
cularly (IM) q 4 hr or 0·01 to 0·02 mg/kg buprenorphine IM or subcutaneously q 6 hr to q 8 109 
hr postoperatively as required (based on pain assessment) and 0·1 mg/kg meloxicamb q 24 hr 110 
orally postoperatively for analgesia. Perioperative antibiosis was administered in the form of 111 
potentiated amoxicillinc, 20 mg/kg q 2 hr during anaesthesia, followed by five days of 20 112 
mg/kg potentiated amoxicillind orally in some dogs. The sphincter was not inflated at the time 113 
of placement.  114 
 115 
Follow-up 116 
 Follow-up intervals varied and any procedures performed at these examinations were 117 
dictated by the needs of each individual dog. Typically dogs were requested to return to the 118 
institution for a routine re-examination six to eight weeks postoperatively. At this re-119 
examination the overall continence rate was assessed, and the presence and severity of dysu-120 
ria, stranguria, haematuria, wound inflammation or infection and length and character of mic-121 
turition were determined by close questioning of the owners and direct observation of the dog 122 
urinating by the examining veterinary surgeon. Remaining follow-up examinations were per-123 
formed by referring veterinarians or the institution as required.  124 
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 Dogs exhibiting dysuria, pain on urination or suspicion of UTI on routine re-125 
examination or on communication with the owner were admitted for repeat urinary tract ul-126 
trasound examination. Postoperatively, only dogs which remained incontinent had urine sam-127 
pled for culture and sensitivity. A urine sample was obtained by cystocentesis and was sub-128 
mitted for urinalysis and/or urine bacterial culture and antibiotic sensitivity. Where UTI (pos-129 
itive bacterial culture or active sediment on urinalysis) was identified, treatment was instigat-130 
ed with appropriate antibiotics based on susceptibility testing, where possible, until a nega-131 
tive urine culture was obtained. Upon documentation of a negative urine culture, and if the 132 
animal was still showing signs of incontinence,  the SHUS was inflated by one injection of 133 
0·1 to 0·5 mL of sterile isotonic (0·9%) sodium chloride (NaCl) into the port following a pro-134 
tocol, previously described.21  135 
Complications were identified and categorized as major or minor using criteria similar 136 
to those previously published. 21Briefly, major complications included those requiring re-137 
placement of the SHUS system. Minor complications were defined as those that did not ne-138 
cessitate replacement of the SHUS, and were often self-limiting. 139 
 140 
Follow-up questionnaire 141 
 Owners and referring veterinarians were contacted and asked to complete a telephone 142 
questionnaire(s) assessing the postoperative progress of the dogs (December 2015). Where 143 
owners could not be contacted, questionnaires were completed where possible based on refer-144 
ring veterinarian records. Continence levels were scored using a scale ranging from 1 (con-145 
stant leakage) to 10 (complete continence), before surgery and at set time points postopera-146 
tively (at discharge, six and 12 months postoperatively, and at the time of the last question-147 
naire).  Details of the scale are given in the appendix 1. Scores of <8 were classified as ‘in-148 
continent’, whereas scores of 8 or more were classed as ‘continent’. Scores were dichoto-149 
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mized this way for easier interpretation in terms of clinical relevance, based on what owners’ 150 
perceive to be acceptable levels of continence. Additionally, owners were asked to grade in 151 
severity (0-3) any complications pertaining to urination noted following surgery, or related to 152 
the implants. A score of 0 indicated that no complications were seen, and scores of 1, 2 and 3 153 
indicated mild, moderate and severe complications, respectively. The significance of a mild, 154 
moderate or severe events was illustrated  by giving precise examples to owners when com-155 
pleting the questionnaire over the phone. Finally, owners were asked to score their satisfac-156 
tion with their dog’s outcome from 1 (very unsatisfied) to 10 (very satisfied), and asked 157 
whether they would have the procedure performed again if they had another dog with the 158 
same problem. Where dogs were euthanized or died before being contacted, owners were 159 
asked to answer  the questionnaire based on their latest recollection of their dog’s status (at 160 
the time of death). 161 
 162 
Statistical analysis 163 
Statistical analysis was performed by use of a commercial software.f Data were tested for 164 
normality using Kolmogorov-Smirnov tests; age, body weight and time to follow-up were 165 
normally distributed and were reported as the mean (SD); duration of hospitalization, owner 166 
satisfaction scores and continence scores were not normally distributed and reported as medi-167 
an (range). A Friedman test for repeated measures was first performed to assess any overall 168 
difference between the repeated continence scores on each subject, pre-operatively with those 169 
at discharge, 6 months, and 12 months and at last follow-up. Given an overall significance, 170 
differences between paired time points were then assessed using a paired-samples sign 171 
test.  P value <0·05 was considered significant. 172 
 173 
 174 
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 185 
Results 186 
Twenty female dogs met the inclusion criteria. Eighteen were 18 spayed and two en-187 
tire. Table 1 shows the signalment, preoperative treatment, diagnostic imaging findings and 188 
cuff size used along with their respective volumes of total inflation. Mean age was 61.0 189 
months (±24.0) and median weight was 27.7 kg (9.6 - 62.7 kg). All included spayed female 190 
dogs were first noticed to be incontinent soon after routine ovariohysterectomy (days to 191 
weeks). Seventeen of the twenty dogs had either failed to respond completely to medical 192 
management with one or more of a combination of PPA, estriol or ephedrine, or had initially 193 
responded but then become incontinent despite medication. None of the dogs had experi-194 
enced adverse effects attributable to medication. Dog 13 did not receive any medical treat-195 
ment for USMI prior to surgical treatment as the owner wished to pursue surgery only. Dogs 196 
two and 10 were selected for surgery despite adequate medical control of incontinence due to 197 
difficulties with administering medication. Physical examination and diagnostic imaging re-198 
vealed urogenital abnormalities in 11/20 dogs (Table 1). No dog had a UTI at the time of sur-199 
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gery, based on the results of urinalysis and bacteriology assessment. Median pre-operative 200 
continence score was 3.0 (2-6). 201 
No intraoperative complications were encountered during surgery, and all dogs were 202 
urinating without difficulty the following day, although 12/20 remained incontinent at dis-203 
charge (Table 2).  Median immediate postoperative continence score (8.0 (2-10)) was signifi-204 
cantly higher than median pre-operative score (P<0.001). Median postoperative 205 
hospitalization time was 2 days (1 to 3 days). 206 
Median continence scores at 6- and 12-months postoperatively were 8.5 (4-10) and 207 
9.0 (5-10) respectively. These were both significantly higher than preoperatively scores 208 
(P<0.001). Mean time at latest follow-up was 1205.4 days (627.4) (Table 2). At this time, 209 
80% of dogs (16) were continent without any other treatment, 10% of dogs (two) were 210 
continent and on continued medical therapy (dogs 3 on 1mg estriol q 24 hr and PPA and dog 211 
14 on PPA and estriol) and two dogs were judged incontinent based on lower continence 212 
scores (both had continence scores of 7). Continence score was 9.0 (7-10) and was signifi-213 
cantly higher than pre-operatively (P<0.001). Communication was not possible with the 214 
owners of four dogs (dogs 9, 13, 19 and 20) at the time of latest follow-up and therefore, in-215 
formation were gathered through communication with the referring veterinarian. Over the 216 
study period, 4/20 dogs (dogs 1, 2, 6 and 12) were euthanized for reasons unrelated to USMI. 217 
All of these dogs had a follow-up time >12 months before euthanasia.  218 
Regarding management of ongoing incontinence, one dog (dog 8) received a course 219 
of PPA to control persistent post-operative incontinence, as the authors were reluctant to in-220 
flate the cuff in this dog due to concurrent dysuria. Dysuria resolved without treatment after 221 
several weeks and incontinence subsequently resolved with inflation of the SHUS and cessa-222 
tion of the PPA. Seven of the 20 dogs (35%) did not require any inflation of the SHUS. Thir-223 
teen required inflation and four of these dogs required subsequent deflation of the cuff, due to 224 
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urinary retention (dog 1), severe dysuria (dogs 2 and 6), or urethral obstruction (dog 11). Two 225 
dogs (dogs 1 and 2) had their cuff completely deflated, and two dogs (dogs 6 and 11) had par-226 
tial deflation (see Table 2 for details).   227 
Minor complications were reported in 13/20 dogs (65%) and are further detailed in 228 
Table 3. Complications were experienced at a variety of times postoperatively. All complica-229 
tions, with one exception, were minor. One dog (dog 1) experienced a major complication 230 
event and required surgical intervention for SHUS removal 28 months postoperatively due to 231 
persistent post-operative stranguria. Seven dogs had postoperative UTIs. One additional dog 232 
(dog 10) had a UTI before (but not at the time of surgery) and after surgery. E.coli infection 233 
was initially identified in this dog, which was sensitive to and treated with amoxicil-234 
lin/clavulanic acid. Persistent recurrent dysuria was reported post-operatively and this was 235 
treated presumptively by the referring veterinarian with amoxicillin/clavulanic acid. Culture 236 
and sensitivity was then performed six days postoperatively; Multi-drug resistant (MDR) 237 
Escherichia coli, Enterobacteriae and Pseudomonas spp. were identified which were sensitive 238 
to amoxicillin/clavulanic acid. For all other dogs where a UTI was suspected based on clini-239 
cal signs, urinalysis and a positive response to antibiotics, no culture and sensitivity infor-240 
mation was available.  Pain surrounding the subcutaneous port, which was responsive to an-241 
algesia, was noted in two dogs during the first two to three weeks postoperatively. 242 
Median owner satisfaction score was 9.5 (5-10). All but one owner, who said he was 243 
unsure (dog 15, satisfaction score of 8) said that they would have the procedure performed 244 
again if they had another dog with the same problem. We also noted lack of compliance with 245 
our recommendations (i.e. owner unwilling to come back for cuff inflation) from two owners. 246 
Those were the dogs with the lower continence scores at follow up (continence score of 7).  247 
 248 
Discussion 249 
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This retrospective study reports the long-term outcome of SHUS for the management 250 
of USMI in female dogs, with a longer time to follow-up (mean 40 months) than has previ-251 
ously been described (26-30 months 22; 13.5 months; 21 12.5 months; 23  32 months 24). It is 252 
important to document long-term efficacy of surgical techniques for USMI, as, for example, 253 
dogs treated with urethral injections of collagen showed good initial success, but over half of 254 
dogs become incontinent approximately 12-16 months postoperatively 14 15  and PTFE injec-255 
tions had an initial 100% success rate but many dogs developed recurrent incontinence over 256 
time. 14  It is vital that veterinarians have a good understanding of the likely outcomes of the 257 
technique and are aware of the possible short- and long-term complications. The long-term 258 
continence rate is higher (90% with 2 cases having medical management) than for colposus-259 
pension (53% and 37% being improved or more responsive to medical treatment), 7  ure-260 
thropexy (56%) 11 or combination of both (70% ) 12  or urethral bulking agents (68%); 14 mean 261 
follow up in the latter two studies was comparable to this study at around three years. Fur-262 
thermore, the two dogs classed as incontinent (continence scores <8) did not have a proper 263 
cuff management due to lack of owner compliance. Avoiding the financial costs associated 264 
with ongoing medical management and expensive repeat surgery is a benefit of SHUS 265 
placement compared to other techniques (only one dog required repeat surgery in this study). 266 
Another major benefit of the SHUS that is not possible with any other reported technique is 267 
the flexibility provided by the ability to inflate or deflate the SHUS at any stage following 268 
surgery, in a conscious dog with minimal equipment. Importantly, owner satisfaction scores 269 
were very high in this study and all but one owner agreed that they would have the same 270 
treatment performed again. This is similar to owner satisfaction reported in an other study 23  271 
where 24/27 owners were satisfied or very satisfied with the procedure. 272 
In the authors’ experience the surgical procedure is simple to perform and requires 273 
minimal additional specialized equipment, apart from the implants and a non-coring Huber 274 
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needle. Certain aspects of the technique, however, require special attention. Care must be 275 
taken to avoid bubble formation in the system and to ensure adequate slack is left in the tub-276 
ing to avoid kinking of the SHUS at the urethra. Secure attachment of the tubing to the injec-277 
tion port is also particularly important. Finally, close monitoring of the dog for at least 24 278 
hours postoperatively for ease and character of urination is essential. 279 
SHUS can be used to treat dogs with incontinence due to multiple different causes 280 
other than USMI 24 and in males dogs with USMI. 23  We have purposely decided to restrict 281 
this study to the female population of dogs treated for USMI (which is the most common 282 
cause of incontinence seen in our hospital). We believed that adding male dogs or dogs pre-283 
sented for urinary incontinence due to conditions other than USMI would add variability and 284 
have weakened the conclusions of the present report.  285 
Ninety percent of our dogs (where two are being managed medically) achieved conti-286 
nence at long term follow up, similar to Currao et al. study 24  where all 18 dogs had signifi-287 
cantly improved continence scores immediately after SHUS placement, and 67% with conti-288 
nence scores > 9 at long term follow up. A median continence score of 9 out of 10 at last fol-289 
low-up was reported by Reeves et al.23 In Rose et al. study 22  all dogs were continent after 290 
the placement of the SHUS (including one dog on medical management for a few months to 291 
maintain a continence score 9 out of 10) and were continent at mean latest follow-up of 30 292 
months without complications. The two dogs on medical management post-operatively in this 293 
study achieved good continence scores, despite not being responsive to medical management 294 
before surgery. They were not completely continent as their owners decided to not pursue 295 
further inflations and decided to continue with medication; the authors believe it is likely that 296 
medications could have been stopped if further cuff inflation had been performed.  297 
Despite the SHUS being left uninflated at the time of surgery (only a small residual 298 
primer volume was used to fill the tubing and injection port), 85% dogs showed improved 299 
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continence immediately after surgery. A period of 6-8 weeks was allowed between surgical 300 
placement and inflation of the SHUS based on previous recommendations in human and vet-301 
erinary studies. 22 27  This is proposed to allow adequate revascularization of the dissected 302 
urethra and minimize the risk of urethral atrophy and erosion. The immediate postoperative 303 
improvement in continence seen in this study was also appreciated in previous reports. 22 23 It 304 
is hypothesized that this occurs due to the passive increase in urethral tone created by the 305 
presence of the semi-rigid backing on the urethral part of the implant. 22 23  Similar to our re-306 
sults (7 dogs, 35%) 33% of dogs reported by Currao et al. 24  did not require inflation to 307 
achieve continence. 308 
Only one major complication was reported in the current case series, (one dog that 309 
had to have the SHUS removed) in agreement with previous reports of the SHUS technique. 310 
22 23 One or more minor complications occurred in 65% dogs, a lower incidence than in our 311 
previous study (81.8%).21 This report included the first 11 dogs of the current study, suggest-312 
ing that complication rate has improved with more experience of the technique. Although 313 
complications were encountered more commonly than reported with other techniques, 7 11 314 
they were minor and self-limiting. Only one dog required further surgery to remove the cuff, 315 
28 months after it was placed. This dog was moderately persistently stranguric despite com-316 
plete deflation of the cuff. Postoperative or post-cuff inflation stranguria was seen in seven 317 
additional cases. Deflation of the SHUS was performed, resulting in resolution of stranguria 318 
in all dogs without further intervention. This is a similar experience to stranguric dogs previ-319 
ously reported. 22  The severity of the stranguria and the presence of urinary retention were 320 
considered when determining whether cuff deflation was indicated. It was thought in retro-321 
spect that stranguria was caused by overinflation of the cuff in dog 1, where 33% of the total 322 
cuff volume was instilled initially. In subsequent dogs, a more gradual SHUS inflation (10 to 323 
20% increments) was therefore performed to reduce the risk of stranguria, in line with the 324 
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recommendations by Rose et al. 22  Reeves et al. 23 reported mild stranguria seven to ten days 325 
after surgery in five dogs, which responded to non-steroidal anti-inflammatories in all 326 
animals. Stranguria and anuria are reported complications of colposuspension and ure-327 
thropexy, requiring postoperative catheterisation in the case of colposuspension and repeat 328 
surgery and suture removal in urethropexy. 7 11  Martinoli et al. reported dysuria in some dogs 329 
where both techniques were combined.12 When these complications occur following SHUS 330 
placement, this study shows that they are more easily and less invasively managed than with 331 
the two aforementioned techniques. 332 
The most common complication in this population appeared to be post-operative 333 
UTIs. According to a study by Wong et al., dogs that had one or two single events of UTI 334 
documented were consider to have uncomplicated UTIs which may even have been related to 335 
USMI.28  Olin and Bartges proposed that all dogs with UTIs related to USMI would be called 336 
complicated. 29  UTIs occurred in eight cases out of 20 dogs (40%), based on a combination 337 
of urinalysis, positive urine bacterial culture and response to antibiotics. This is a significant 338 
proportion of dogs, although two out of eight cases where information was available had sin-339 
gle UTIs. Three dogs had multiple (three and over) UTI events and in these animals the au-340 
thors consider that they had complicated UTIs. Due to lack of records, the nature of these in-341 
fections (for example if they involved the same organism, or MDR organisms and whether or 342 
not significant clinical signs were associated) was unknown. All UTIs were successfully 343 
treated with antibiotics based on resolution of clinical signs. It is clear that more information 344 
is needed regarding the association between SHUS and UTIs as it is possible that some of the 345 
cases of UTIs post SHUS placement may simply be related to the higher prevalence of UTIs 346 
in incontinent female dogs and not necessarily linked with the presence of the SHUS.  Only a 347 
more stringent protocol involving routine urine culture and sensitivity irrespective of the 348 
presence of clinical signs could provide information on the prevalence of subclinical infec-349 
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tions. We can therefore not exclude the presence of subclinical infection in some of the dogs 350 
included in this study as only dogs with clinical signs consistent with UTIs were further in-351 
vestigated with urine culture and sensitivity.   352 
. Because pain surrounding the subcutaneous port was noted in two dogs during the 353 
first two to three weeks postoperatively, the authors modified the port placement technique 354 
by moving the location of the port from the medial musculature of the pelvic limb/inguinal 355 
region to the paramedian abdominal wall. Pain was not suspected in any subsequent dog, and 356 
that location of the port allowed it to be more easily identified on palpation and also likely 357 
reduced port movement.  358 
Prolonged duration of micturition compared to that preoperatively was reported in 359 
50% dogs. This is far less frequent than that noted in a previous study where three out of four 360 
animals (75%) presented with this complication. 22  To the authors’ knowledge, this is not a 361 
reported complication following colposuspension or urethropexy and is considered a more 362 
severe form of prolonged emptying. The significance of prolonged micturition in these dogs 363 
is unknown but may indicate discomfort when urinating, or smaller urethral diameter due to 364 
the SHUS placement and rather inelastic fibrous tissue formation around the urethra at this 365 
particular level. 366 
One dog had a known obstructive episode (managed by slight cuff deflation) and 367 
three additional dogs had suspected low-grade ongoing urinary retention. Although urinary 368 
retention did not result in obvious additional complications, it is a known risk factor for UTI 369 
development. This may contribute to UTI development in dogs treated with SHUS cases, alt-370 
hough this case series is too small to allow this association to be evaluated fully. It is now 371 
considered prudent to counsel owners regarding the potential postoperative risks of urinary 372 
retention. We recommend that the bladder is routinely checked post-micturition (by palpation 373 
and/or ultrasound examination) by the referring veterinarian every three months during the 374 
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first year postoperatively and then as required, based on the initial presence or degree of uri-375 
nary retention. 376 
This study has a number of limitations, primarily due to its retrospective nature. Some 377 
data were reliant on owner recall ability and in any case were subjective, despite efforts to 378 
classify continence scores and complication severity on numeric scales. Inter-observer varia-379 
bility and bias were unavoidable disadvantages of data collection by owner questionnaire. 380 
Owner satisfaction would also have depended on pre-existing expectations, influenced by 381 
preoperative counseling, owner education, understanding of the procedure and expected out-382 
come. A contemporaneous record of the continence levels, recorded at the specified time in-383 
tervals, would be more reliable. This said, owners’ perceptions are increasingly being recog-384 
nized as important outcome indicators, rather than using objective scientific criteria alone. 30  385 
Additionally, bacteriuria may have been missed due to clinical signs only prompting further 386 
investigations for a possible infection. 387 
388 
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Conclusion 389 
Overall, SHUS is an effective treatment for USMI in bitches, resulting in a significant 390 
improvement in continence scores, in both the short- and long-term (>12 months). This study 391 
shows that 90% of dogs achieve continence and that owners were very satisfied with their 392 
dogs’ outcome. It confirms that a major advantage of the SHUS is that it provides scope for 393 
potentially further improving continence postoperatively (without surgery and without further 394 
medication) by cuff inflation, although this is not required in all dogs. According to this 395 
study, long-term management of SHUS does not seem to result in a high incidence of implant 396 
–related complications. Results are of importance as they add to the currently limited body of 397 
evidence available for veterinarians regarding the use of SHUS. 398 
 399 
400 
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Footnote list  401 
a : Prolene, Ethicon, Norderstedt, Germany 402 
b : Metacam, Boehringer Ingelheim Ltd, Bracknell, UK 403 
c: Augmentin, GlaxoSmithKline, Brentford , UK 404 
d: Clavaseptin, Vetoquinol UK Ltd Buckingham, UK 405 
e: Access Technologies, Skokie, IL 406 
f: Systat, version 10.0, SPSS Inc, Chicago, Ill  407 
PPA: phenylpropanolamine  408 
USMI: Urethral sphincter mechanism incompetence 409 
UTI:  urinary tract infection 410 
SHUS: static hydraulic urethral sphincter 411 
PTFE: polytetrafluoroethylene 412 
IVU: intravenous contrast urography 413 
IV: intravenously 414 
IM: intramuscularly 415 
MDR: multi-drug resistant 416 
417 
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Table 1: Signalment, preoperative findings and inflation/deflation volumes for SHUS for 20 1 
female dogs. 2 
Dog Breed 
Body weight 
(Kg) 
Age at 
surgery 
(months) 
Preoperative 
treatment 
Imaging 
findings 
SHUS size 
(mm) (total 
volume, ml) 
1 Irish Setter 31.9 100 PPA 
Intrapelvic 
bladder 
12 (1.5) 
2 Rottweiller X 52.3 31 PPA / estriol NSF 10 (1.45) 
3 Labrador 27.5 84 Ephedrine 
Intrapelvic 
bladder 
10 
4 Irish Setter 32 63 PPA / estriol 
Intrapelvic 
bladder 
10 (0.9) 
5 WHWT 9.6 54 PPA / estriol NSF 6 (1) 
6 Border Collie 23.5 80 PPA / estriol 
Pyelectasia 
and intrapelvic 
bladder 
8 (1) 
7 Springer Spaniel 14.5 88 PPA / colpo 
Mild vaginal 
stricture 
8 (1) 
8 Dobermann 38.3 33 PPA 
Intrapelvic 
bladder and 
perivulvar 
dermatitis 
10 (0.8) 
9 Labrador 24.5 72 PPA / estriol NSF 10 (0.8) 
10 Labrador 27.9 77 PPA/ estriol NSF 10 (1.2) 
11 Dobermann 34.8 60 PPA / estriol NSF 10 (2) 
12 Dobermann 27.9 72 PPA / estriol 
Intrapelvic 
bladder 
12 (1.5) 
13 Great Dane 62.65 23 None 
Intrapelvic 
bladder 
10 (1.2) 
14 Boxer 24.9 60 PPA / estriol NSF 10 (1) 
15 Weimaraner 25.6 83 PPA 
Intrapelvic 
bladder 
10 (2) 
16 Springer Spaniel 22.5 80 PPA / estriol NSF 10 (1.2) 
17 Mastiff 40.1 26 PPA 
Intrapelvic 
bladder 
10 (1.2) 
18 Labrador 25 36 PPA / estriol NSF 10 
19 Dobermann 31.3 25 Estriol 
Mild renal 
dysplasia and 
intrapelvic 
bladder 
10 
20 Collie X 25 73 PPA / estriol NSF 10 
Mean  30.1  61     
S.D.  11.8 24.0    
NSF- no significant findings; PPA- phenylpropanolamine; Colpo- colposuspension; WHWT- 3 
west highland white terrier; S.D.-standard deviation 4 
 5 
 6 
 7 
 8 
 9 
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 10 
 11 
Table 2: Owner-rated continence scores, total number and volume of inflations/deflations 12 
performed and time at last follow-up. 13 
Dog 
Continence score (0-10) Total 
number of 
inflations 
(total 
volume of 
inflation, 
mL) 
Total 
number of 
deflations 
(total 
volume of 
deflation, 
mL) 
Time at 
last 
follow-
up 
(days) 
Pre- op Discharge 6-months 
12-
months 
Latest 
follow-up 
1 2 4 4 10 10 (PTS) 3 (0.75) 2 (0.75) 1279 
2 4 10 6 7 7 (PTS) 1 (0.3) 1 (0.1) 428 
3 6 8 10 5 9* 4 (0.5) 0 2044 
4 3 2 10 10 9 0 0 1884 
5 3 3 7 7 8 1 (0.2) 0 1853 
6 6 8 5 9 10 (PTS) 4 (0.8) 1 (0.2) 1095 
7 4 10 8 8 8 0 0 1779 
8 2 6 8 8 9.5 2 (0.4) 0 1519 
9 3 8 8 9 9  0 0 1090 
10 5 6 10 10 10 9 (1.05) 0 790 
11 2 2 4 9 8 6 (0.65) 1 (0.35) 454 
12 2 4 10 10 10 (PTS) 5 (0.65) 0 365 
13 6 8 10 10 10  0 0 1424 
14 2 9 10 10 10* 0 0 808 
15 2 9 8 8 7 3 (0.5) 0 806 
16 2 9 10 10 10 1 (0.15) 0 559 
17 2 9 9 9 8 1 (0.15) 0 1290 
18 6 10 9 9 10 0 0 2257 
19 2 5 9 9 9  0 0 2093 
20 6 9 8 8 8  1 (0.15) 0 365 
Median 3.0 8.0 8.0 9.0 9.0  Mean 1205.4 
Range 2-6 2-10 4-10 5-10 7-10  SD 627.4 
PTS=euthanized, *dogs also receiving medical management 14 
  15 
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Table 3: Severity scores (0-3 in increasing severity) of complications following SHUS 16 
placement. 17 
Dog Urinary complications Wound / port complications 
Stranguria Haematuria Urinary infection Pain on 
Urination 
Longer 
micturition 
time 
Seroma Infection Pain Healing 
Score When 
occurred  
Number of 
events 
1 2 0 1 Post 
operatively 
Single 
event 
0 2 1 0 0 0 
2 3 2 3 Post 
operatively 
Multiple 
events 
2 3 0 0 0 0 
3 0 0 0   0 1 0 0 0 0 
4 0 0 0   0 0 0 0 0 0 
5 0 0 0   0 0 0 0 0 0 
6 3 0 3 Post 
operatively 
Multiple 
events 
1 1 0 0 1 0 
7 0 0 3 Post 
operatively 
Multiple 
events 
0 1 1 0 0 0 
8 2 0 0   0 2 3 0 0 0 
9 2 0 2 Post 
operatively 
Single 
event 
0 2 0 0 0 0 
10 0 2 2 Pre and 
post 
operatively 
Multiple 
events 
0 0 0 0 0 0 
11 1 0 0   0 2 0 0 0 0 
12 1 0 0   0 1 0 0 0 0 
13 0 0 0   0 0 0 0 0 0 
14 0 0 1 Information 
not 
available  
Information 
not 
available  
0 1 0 0 0 0 
15 0 0 0   0 0 0 0 0 0 
16 0 0 0   0 0 1 0 0 0 
17 0 0 0   0 0 0 0 0 0 
18 3 0 2 Information 
not 
available  
Information 
not 
available  
0 0 1 0 0 0 
19 0 0 0   1 0 0 0 2 0 
20 0 0 0   0 0 0 0 0 0 
Complication score = 0- none /complete healing, 1- mild, 2- moderate, 3-severe;  18 
 19 
